Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

Advisory Committee on Immunization Practices

FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION

ACIP Recommendations: Vaccine index

View all HPV Plague Tetanus
Anthrax Influenza Pneumococcal Typhoid
Chickenpox Japanese encephalitis Polio Yellow fever
Diphtheria Measles Rabies Zoster
Hib Meningococcal Rotavirus
Hepatitis A Mumps Rubella
Hepatitis B Pertussis Smallpox
 

Recommendations - Anthrax

Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
Source: MMWR, July 23, 2010; 59(rr06):1-36
HTML  |  PDF
 
Use of Anthrax Vaccine in Response to Terrorism
Source: MMWR, November 15, 2002, Vol. 51(45):1024-1026
HTML  |  PDF
 
Use of Anthrax Vaccine in the United States
Source: MMWR December 15, 2000 / Vol. 49 / No. RR-15 
HTML  |  PDF
#

Recommendations - Chickenpox (varicella)

Updated Recommendations for Use of VariZIG -- United States, 2013
Source: MMWR, July 19, 2013; 62(28):574-6
HTML  |  PDF
 
Prevention of Varicella
Source: MMWR, June 22, 2007; 56(RR-4):1-40
HTML  |  PDF
 
Investigational Product (VariZIG™) for Postexposure Prophylaxis of Varicella
Source: MMWR, February 24, 2006, Vol. 55:1-2
HTML  |  PDF
#

Recommendations - Diphtheria

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, February 22, 2013;62(07):131-5
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
Source: MMWR, June 29, 2012; 61(25):468-70
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months -- Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, October 21, 2011; 60(41):1424-1426
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
Source:: MMWR, January 14, 2011; 60(01):13-15
HTML  |  PDF
 
Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 30, 2008; 57 (04):1-47,51
HTML pt 1  | HTML pt 2  | HTML pt 3  | PDF
 
Preventing Tetanus, Diphtheria, and Pertussis among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
Please note: If you are using the HTML version of this document, be sure to access all four HTML links to get the complete content of the document, which includes 3 important appendices.
Source: MMWR, December 15, 2006;55(RR-17):1-33
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  PDF (entire issue)
 
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among Adolescents
Please note: If you are using the HTML version of this document, be sure to access all the HTML links to get the complete content of the document, which includes important appendices.
Source: MMWR, March 24, 2006, Vol. 55(RR03):1-49
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  HTML pt.5 |  HTML pt.6  |  HTML pt.7  |  PDF (entire issue)
 
Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series
Source: MMWR November 17, 2000 / Vol. 49 / No. RR-13
HTML  |  PDF
 
Diphtheria, Tetanus, and Pertussis, Recommendations for Vaccine Use and Other Preventive Measures
Source: MMWR August 8, 1991 / Vol. 40 / No. RR-10
HTML  |  PDF
#

Recommendations - Haemophilus influenzae type b (Hib)

Back to top
Prevention and Control of Haemophilus influenzae Type b Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Recommendations and Reports
Source: MMWR, February 28, 2014; 63(RR01):1-14
HTML  |  PDF
 
Licensure of a Haemophilus influenzae Type b (Hib) Vaccine (Hiberix) and Updated Recommendations for Use of Hib Vaccine
Source: MMWR September 18, 2009; 58(36):1008-1009
HTML  |  PDF
 
Updated Recommendations for Use of Haemophilus influenzae Type b (Hib) Vaccine: Reinstatement of the Booster Dose at Ages 12 -15 Months
Source: MMWR, June 26, 2009; 58(24):673-4
HTML  |  PDF
 
Use of Haemophilus b Conjugate Vaccines and a Combined DTP and Hib Vaccine
Source: MMWR September 17, 1993 / Vol. 42 / No. RR-13
HTML  |  PDF
 
Haemophilus b Conjugate Vaccines for Prevention of Hib Disease
Source: MMWR January 11, 1991 / Vol. 40 / No. RR-01
HTML  |  PDF
#

Recommendations - Hepatitis A

Sexually Transmitted Diseases Treatment Guidelines, 2010
(Not an ACIP statement but an important document. Includes information on hepatitis A, hepatitis B, and human papillomavirus [HPV] vaccination.)
Source: MMWR, December 17, 2010; 59(RR12):1-110
HTML  |  PDF
 
Updated Recommendations from the Advisory Committee on Immunization Practices (ACIP) for Use of Hepatitis A Vaccine in Close Contacts of Newly Arriving International Adoptees
Source: MMWR, September 18, 2009; 58(36):1006-1007
HTML  |  PDF
 
Update: Prevention of Hepatitis A after Exposure to Hepatitis A Virus and in
International Travelers
Source: MMWR, October 19, 2007; 56(41):1080-1084
HTML  |  PDF
 
Prevention of Hepatitis A Through Active or Passive Immunization
Source: MMWR, May 19, 2006, Vol. 55(RR07):1-23
HTML  |  PDF
 
Correctional Settings: Prevention and Control of Infections with Hepatitis Viruses in Correctional Settings
(not an ACIP statement but an important document)

Source: MMWR, January 24, 2003, Vol. 52(RR-1):1-44
HTML  |  PDF
#

Recommendations - Hepatitis B

Back to top
CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management – Recommendations and Reports
Source: MMWR, December 20, 2013; 62(rr10);1-19
(Not an ACIP statement but an important document from CDC.)
HTML  |  PDF
 
Updated CDC Recommendations for the Management of Hepatitis B Virus–Infected Health-Care Providers and Students
(Not an ACIP statement but an important document from CDC.)
Source: MMWR, July 6, 2012; 61(RR03):1-12
HTML  |  PDF
 
Use of Hepatitis B Vaccination for Adults with Diabetes Mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, December 23, 2011; 60(50):1709-11
HTML  |  PDF
 
Sexually Transmitted Diseases Treatment Guidelines, 2010
(Not an ACIP statement but an important document. Includes information on hepatitis A, hepatitis B, and human papillomavirus [HPV] vaccination.)
Source: MMWR, December 17, 2010; 59(RR12):1-110
HTML  |  PDF
 
Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection
Source: MMWR, September 19, 2008; 57(RR--8):1-20
(Not an ACIP statement, but an important new recommendation from CDC)
HTML  |  PDF
 
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Part II: Immunization of Adults
Please note: If you are using the HTML version of this document, be sure to access all four HTML links to get the complete content of the document, which includes 3 important appendices.

Source: MMWR, December 8, 2006;55(RR-16):1-25R
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  PDF (entire issue)
 
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Part 1: Immunization of Infants, Children and Adolescents.
Please note: If you are using the HTML version of this document, be sure to access all four HTML links to get the complete content of the document, which includes 3 important appendices.
Source: MMWR, December 23, 2005, Vol. 54(RR-16):1-39
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  PDF (entire issue)
 
Correctional Settings: Prevention and Control of Infections with Hepatitis Viruses in Correctional Settings
(not an ACIP statement but an important document)

Source: MMWR, January 24, 2003, Vol. 52(RR-1):1-44
HTML  |  PDF
 
Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis
(not an ACIP statement but an important update document)
Source: MMWR June 29, 2001 / Vol. 50 / No. RR-11
HTML  |  PDF
 
Recommendations for Preventing Transmission of Human Immunodeficiency Virus and Hepatitis B Virus to Patients During Exposure-Prone Invasive Procedures
(not an ACIP statement but an important document)

Source: MMWR, July 12, 1991 / Vol. 40 / No. RR08
HTML  |  PDF
#

Recommendations - Human papillomavirus (HPV)

Back to top
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, December 23, 2011; 60(50):1705-8
HTML  |  PDF
 
Sexually Transmitted Diseases Treatment Guidelines, 2010
(Not an ACIP statement but an important document. Includes information on hepatitis A, hepatitis B, and human papillomavirus [HPV] vaccination.)
Source: MMWR, December 17, 2010; 59(RR12):1-110
HTML  |  PDF
 
FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 28, 2010; 59(20):626-629
HTML  |  PDF
 
FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from the Advisory Committee on Immunization Practices (ACIP) Weekly
Source: MMWR, May 28, 2010; 59(20):630-632
HTML  |  PDF
 
Quadrivalent Human Papillomavirus Vaccine
Source: MMWR, March 23, 2007; 56(RR02):1-24
 
HTML  |  PDF
#

Recommendations - Influenza

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2014–2015
Source: MMWR, August 15, 2014; 63(327):691–697
HTML  |  PDF
 
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2013–2014
Source: MMWR, September 20, 2013; 62(RR–7):1-48
HTML  |  PDF
 
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2013–2014
Source: MMWR, September 20, 2013; 62(RR–7):1-48
HTML  |  PDF
 
Summary Recommendations: Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2013–14
Released: August 7, 2013
HTML  |  PDF
 
Prevention and Control of Influenza with Vaccines: Interim Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013 Weekly
Source: MMWR, May 10, 2013; 62(18):356
HTML  |  PDF
 
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2012–13 Influenza Season
Source: MMWR, August 18, 2012;61(32);613-8
HTML  |  PDF
 
Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza
Source: MMWR, January 21, 2011; 60(RR01):1-24
HTML  |  PDF
 
Licensure of a High-Dose Inactivated Influenza Vaccine for Persons Aged >=65 Years (Fluzone High-Dose) and Guidance for Use--United States, 2010
Source: MMWR, April 30, 2010; 59(16):485-486
HTML  |  PDF
 
Expansion of Use of Live Attenuated Influenza Vaccine (FluMist) to Children Aged 2-4 Years and Other FluMist Changes for the 2007--08 Influenza Season
Source: MMWR, November 23, 2007; 56(46):1217-1219
HTML  |  PDF
 
Influenza Vaccination of Health-Care Personnel
Source: MMWR, February 24, 2006, Vol. 55(RR02):1-16
HTML  |  PDF
 
Using Live, Attenuated Influenza Vaccine for Prevention and Control of Influenza
Source: MMWR, September 26, 2003, Vol. 52/No. RR-13 (file size 402 KB)
HTML  |  PDF
#

Recommendations - Japanese Encephalitis

Use of Japanese Encephalitis Vaccine in Children: Recommendations of the Advisory Committee on Immunization Practices, 2013
Source: MMWR, November 15, 2013; 62(45):898-900
HTML  |  PDF
Recommendations for Use of a Booster Dose of Inactivated Vero Cell Culture-Derived Japanese Encephalitis Vaccine -- Advisory Committee on Immunization Practices, 2011
Source: MMWR, May 27, 2011; 60(20):661-3
HTML  |  PDF
 
Update on Japanese Encephalitis Vaccine for Children
Source: MMWR, May 27, 2011; 60(20):664-5
HTML  |  PDF
 
Japanese Encephalitis Vaccines
Source: MMWR, March 12, 2010; 59(01):1-27
HTML  |  PDF
 

Recommendations - Measles

Back to top
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 -- Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 14, 2013; 62(RR04):1-34
HTML  |  PDF
 
Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine--Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, May 7, 2010; 59(RR--3):1 - 16
HTML  |  PDF
 
Measles, Mumps, and Rubella--Vaccine Use and Strategies
Source: MMWR May 22, 1998 / Vol. 47 / No. RR-8
HTML  |  PDF
#

Recommendations - Meningococcal

Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease
Source: MMWR, June 20, 2014; 63(24):527-530
HTML  |  PDF
 
Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, March 22, 2013; 62(RR02):1-22
HTML  |  PDF
 
Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale
Source: MMWR, January 25, 2013; 62(3):52-4
HTML  |  PDF
 
Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
Source: MMWR, October 14, 2011; 60(40):1391-2
HTML  |  PDF
 
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 5, 2011; 60(30):1018-1019
HTML  |  PDF
 
Updated Recommendations for Use of Meningococcal Conjugate Vaccines--Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, January 28, 2011; 60(03):72-76
HTML  |  PDF
 
Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use--Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, March 12, 2010; 59(09):273
HTML  |  PDF
 
Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Revaccination of Persons at Prolonged Increased Risk for Meningococcal Disease
Source: MMWR, September 25, 2009; 58(37):1042-1043
HTML  |  PDF
 
Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2--10 Years at Increased Risk for Invasive Meningococcal Disease
Source: MMWR, December 7, 2007; 56(48):1265-1266
HTML  |  PDF
 
Revised Recommendations of the ACIP to Vaccinate All Persons Aged 11--18 Years with Meningococcal Conjugate Vaccine
Source: MMWR, August 10, 2007; 56(31):794-795
HTML  |  PDF
 
Prevention and Control of Meningococcal Disease
Source: MMWR, May 27, 2005, Vol. 54(RR07):1-21
HTML  |  PDF
#

Recommendations - Mumps

Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 -- Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 14, 2013; 62(RR04):1-34
HTML  |  PDF
 
Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine--Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, May 7, 2010; 59(RR--3):1 - 16
HTML  |  PDF
 
Control and Elimination of Mumps
Source: MMWR, June 9, 2006, Vol. 55(22):629-630
HTML  |  PDF
 
Measles, Mumps, and Rubella--Vaccine Use and Strategies
Source: MMWR May 22, 1998 / Vol. 47 / No. RR-8
HTML  |  PDF
#

Recommendations - Plague

Prevention of Plague
Source: MMWR December 13, 1996 / Vol. 45 / No. RR-14
HTML  |  PDF
#

Recommendations - Pertussis

Back to top
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, February 22, 2013;62(07):131-5
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
Source: MMWR, June 29, 2012; 61(25):468-70
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months -- Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, October 21, 2011; 60(41):1424-1426
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
Source:: MMWR, January 14, 2011; 60(01):13-15
HTML  |  PDF
 
Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 30, 2008; 57 (04):1-47,51
HTML pt 1  | HTML pt 2  | HTML pt 3  | PDF
 
Preventing Tetanus, Diphtheria, and Pertussis among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
Please note: If you are using the HTML version of this document, be sure to access all four HTML links to get the complete content of the document, which includes 3 important appendices.
Source: MMWR, December 15, 2006;55(RR-17):1-33
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  PDF (entire issue)
 
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among Adolescents
Please note: If you are using the HTML version of this document, be sure to access all the HTML links to get the complete content of the document, which includes important appendices.
Source: MMWR, March 24, 2006, Vol. 55(RR03):1-49
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  HTML pt.5 |  HTML pt.6  |  HTML pt.7  |  PDF (entire issue)
 
CDC Treatment Guidelines: Recommended Antimicrobial Agents for the Treatment and Postexposure Prophylaxis of Pertussis
(not an ACIP statement but a recommendation from NIP, CDC)
Source: MMWR, December 9, 2005, Vol. 54(RR14):1-16
HTML  |  PDF
 
Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series
Source: MMWR November 17, 2000 / Vol. 49 / No. RR-13
HTML  |  PDF
 
Use of Acellular Pertussis Vaccines
Source: MMWR March 28, 1997 / Vol. 46 / No. RR-7
HTML  |  PDF
 
Diphtheria, Tetanus, and Pertussis, Recommendations for Vaccine Use and Other Preventive Measures
Source: MMWR August 8, 1991 / Vol. 40 / No. RR-10
HTML  |  PDF
#

Recommendations - Pneumococcal

Back to top
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 28, 2013; 62(25):521-524
HTML  |  PDF
 
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, October 12, 2012; 61(40):816-9
HTML  |  PDF
 
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
Source: MMWR, June 1, 2012; 61(21):394-5
HTML  |  PDF
 
Prevention of Pneumococcal Disease Among Infants and Children--Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine
Source: MMWR, December 10, 2010; 59(RR11):1-18
HTML  |  PDF
 
Updated ACIP Recommendations: Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23)
Source: MMWR, September 3, 2010; 59(34):1102-6
HTML  |  PDF
 
Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children --- Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, March 12, 2010; 59(09):258-261
HTML  |  PDF
 
Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24--59 Months Who Are Not Completely Vaccinated
Source: MMWR, April 4, 2008; 57(13):343-344
HTML  |  PDF
 
Pneumococcal Vaccination for Cochlear Implant Candidates and Recipients
Source: MMWR, Early Release, July 31, 2003, Vol. 52;1-2
HTML  |  PDF
 
Preventing Pneumococcal Disease Among Infants and Young Children
Source: MMWR October 6, 2000 / Vol. 49 / No. RR-09
HTML  |  PDF
 
Prevention of Pneumococcal Disease
Source: MMWR April 04, 1997 / Vol. 46 / No. RR-08
HTML  |  PDF
#

Recommendations - Polio

Poliomyelitis Prevention in the United States
Source: MMWR May 19, 2000 / Vol. 49 / No. RR-05
HTML  |  PDF
#

Recommendations - Rabies

Back to top
Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies
Source: MMWR, March 19, 2010; 59(02):1-9
HTML  |  PDF
 
Human Rabies Prevention--United States, 2008: Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, May 23, 2008; 57(RR03):1-26,28
HTML pt 1 | HTML pt 2 |  PDF
#

Recommendations - Rotavirus

Prevention of Rotavirus Gastroenteritis Among Infants and Children: Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, February 6, 2009, Vol. 58 (RR-2)
HTML  |  PDF
#

Recommendations - Rubella

Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 -- Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 14, 2013; 62(RR04):1-34
HTML  |  PDF
 
Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine--Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, May 7, 2010; 59(RR--3):1 - 16
HTML  |  PDF
 
CDC Guidelines: Evaluation and Management of Suspected Outbreaks, Rubella in Pregnant Women, and Surveillance for Congenital Rubella Syndrome
(not an ACIP statement but an important update document)
Source: MMWR July 13, 2001 / Vol. 50 / No. RR-12
HTML  |  PDF
 
Measles, Mumps, and Rubella--Vaccine Use and Strategies
Source: MMWR May 22, 1998 / Vol. 47 / No. RR-8
HTML  |  PDF
#

Recommendations - Shingles (zoster)

Prevention of Herpes Zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 6, 2008; 57(05):1-30
HTML  |  PDF
#

Recommendations - Smallpox

Back to top
Recommendations for Using Smallpox Vaccine in a Pre-Event Vaccination Program
Source: MMWR, Recommendations and Reports, April 4, 2003, Vol. 52(RR-7)
HTML  |  PDF
 
Vaccinia (Smallpox) Vaccine
Source: MMWR June 22, 2001 / Vol. 50 / No. RR-10
 
HTML  |  PDF
#

Recommendations - Tetanus

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, February 22, 2013;62(07):131-5
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
Source: MMWR, June 29, 2012; 61(25):468-70
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months -- Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, October 21, 2011; 60(41):1424-1426
HTML  |  PDF
 
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
Source: MMWR, January 14, 2011; 60(01):13-15
HTML  |  PDF
 
Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 30, 2008; 57 (04):1-47,51
HTML pt 1  | HTML pt 2  | HTML pt 3  | PDF
 
Preventing Tetanus, Diphtheria, and Pertussis among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
Please note: If you are using the HTML version of this document, be sure to access all four HTML links to get the complete content of the document, which includes 3 important appendices.
Source: MMWR, December 15, 2006;55(RR-17):1-33
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  PDF (entire issue)
 
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among Adolescents
Please note: If you are using the HTML version of this document, be sure to access all the HTML links to get the complete content of the document, which includes important appendices.
Source: MMWR, March 24, 2006, Vol. 55(RR03):1-49
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  HTML pt.5 |  HTML pt.6  |  HTML pt.7  |  PDF (entire issue)
 
Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series
Source: MMWR November 17, 2000 / Vol. 49 / No. RR-13
HTML  |  PDF
 
Diphtheria, Tetanus, and Pertussis, Recommendations for Vaccine Use and Other Preventive Measures
Source: MMWR August 8, 1991 / Vol. 40 / No. RR-10
HTML  |  PDF
#

Recommendations - Typhoid

Typhoid Immunization
Source: MMWR December 9, 1994/ Vol. 43/ No. RR-14
HTML  |  PDF
#

Recommendations - Yellow Fever

Back to top
Yellow Fever Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, July 30, 2010; 59(RR07):1-27
HTML  |  PDF
 
Yellow Fever Vaccine
Source: MMWR, November 8, 2002, Vol. 51/RR17
HTML  |  PDF
This page was reviewed on August 19, 2014
Immunization Action Coalition  •  Saint Paul, MN
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.